Advanced Therapy Medicinal Products (ATMP) are biopharmaceuticals that contain living cells, gene therapy components, tissues, or viruses. These products aim to treat diseases that traditional medicines cannot effectively address, such as genetic disorders, cancers, and severe tissue damage. ATMP products can be divided into three main categories: cell therapy products, gene therapy products, and tissue-engineered products. Additionally, there are combination products that integrate a biological component with a medical device.
ATMP products differ significantly from traditional medicines, such as tablets. They contain living cells or viruses that act as active therapeutic agents. This brings unique challenges, particularly in terms of production, quality assurance, and regulation. Traditional medicines, like tablets, consist of chemical compounds, and their manufacturing process is highly standardized and reproducible. In contrast, ATMP products involve the use of living cells or biological components, making the process more complex and challenging.
The complexity in manufacturing ATMP products arises from the need to grow and modify cells in precisely controlled conditions that mimic the natural environment. Even small changes in conditions, such as temperature, pH, or nutrients, can affect the quality and efficacy of the product. Many ATMP products are manufactured on a patient-specific basis, with each batch potentially differing slightly due to biological variation. This increases the complexity of quality assurance, as each batch must be individually analyzed. Additionally, the analysis of ATMP products involves complex biological tests, such as assessing cell viability, purity, and genetic stability, which differ significantly from the chemical analyses of tablet products.
From the perspective of a Qualified Person (QP), the job responsibilities are very similar in both traditional pharmaceutical industries and the ATMP sector. The QP is responsible for ensuring that products meet all quality requirements and regulatory standards. Successfully fulfilling this role requires close collaboration with production, quality control, and regulatory authorities.
In the ATMP sector, the QP’s work is particularly challenging and interesting due to the complexity of the manufacturing process and the unique characteristics of biological analyses. The QP must understand how the process is validated, how process parameters and quality requirements are defined, and their impact on product quality. The world of ATMP product analysis is filled with biological tests, so the QP must be proficient in understanding these tests and interpreting the results. The presence of living components in the process introduces unexpected and variable factors, making the ATMP sector particularly challenging and fascinating. This requires the QP to have deep expertise and the ability to adapt to constantly changing conditions.
